Thyroid cancer with concurrent hyperthyroidism

Archives of Surgery

Volumn 134, Issue 2, 1999, Pages 130-134

  Chao, Tzu Chieh ^a   Lin, Jen Der ^a   Jeng, Long Bin ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; LIOTHYRONINE; LUGOL; PROPYLTHIOURACIL; SODIUM IODIDE I 131; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; MALE; METASTASIS; PRIORITY JOURNAL; RADIOIODINATION; RISK ASSESSMENT; RISK FACTOR; THYROID FOLLICULAR CARCINOMA; THYROID HORMONE BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0033025371     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.2.130     Document Type: Article

References (36)

1. Shapiro ST, Friedmann NB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves' disease. Cancer. 1970;26:1261-1270.
2. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves' disease. World J Surg. 1990;14:437-441.
3. Wahl RA, Goretzki P, Meybier H, Nitschke J, Linder M, Roher H-D. Coexistence of hyperthyroidism and thyroid cancer. World J Surg. 1982;6:385-390.
4. Rieger R, Pimpl W, Money S, Rettenbacher L, Galvan G. Hyperthyroidism and concurrent thyroid cancer. Surgery. 1989;106:6-10.
5. Behar R, Arganini M, Wu T-C, et al. Graves' disease and thyroid cancer. Surgery. 1986;100:1121-1127.
6. Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab. 1990;70:830-835.
7. Hales IB, McElduff A, Crummer P, et al. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab. 1992;75:886-889.
8. Edmonds CJ, Tellez M. Hyperthyroidism and thyroid cancer. Clin Endocrinol. 1988; 28:253-259
9. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992;72:667-697.
10. Doniach I. The effect of radioactive iodine alone and in combination with methylthiouracil upon tumor production in the rat's thyroid gland. Br J Cancer. 1953; 7:181-202.
11. Ichikawa Y, Saito E, Abe Y, Homma M, Muraki T, Ito K. Presence of TSH receptor in thyroid neoplasms. J Clin Endocrinol Metab. 1976;42:395-398.
12. Pujol P, Daures J-P, Nsakala N, Baldet L, Bringer J, Jaffiol C. Degree of thyrotropin suppression as a prognostic determination in differentiated thyroid cancer. J Clin Endocrinol Metab. 1996;81:4318-4323.
13. Rossi RL, Cady B, Silverman ML, et al. Surgically incurable well-differentiated thyroid carcinoma: prognostic factors and results of therapy. Arch Surg. 1988; 123:569-574.
14. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment of 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063-1075.
15. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester J, Fremgen A. Survival discriminants for differentiated cancer. Am J Surg. 1990;160:344-347.
16. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev. 1988;9:106-121.
17. Sugino K, Mimura T, Ozaki O, et al. Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy. World J Surg. 1995; 19:648-652.
18. Filetti S, Belfiore A, Amir SM, et al. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med. 1988;318:753-759.
19. Di Paola R, Menzaghi C, De Filippis V, Corda D, Di Cerbo A. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab. 1997;82:670-673.
20. Miki H, Oshimo K, Inoue H, et al. Diagnosis and surgical treatment of small papillary carcinomas of the thyroid gland. J Surg Oncol. 1993;54:78-81.
21. Allo MD, Christianson W, Koivunen D. Not all "occult" papillary carcinomas are "minimal." Surgery. 1988;104:971-976.
22. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg. 1981;142:474-479.
23. Schroder DM, Chambors A, France CJ. Operative strategy for thyroid cancer: is total thyroidectomy worth the price? Cancer. 1986;58:2320-2328.
24. Farrar WB, Cooperman M, James AG. Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg. 1980;192:701-704.
25. Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139-1147.
26. Clark OH, Levin K, Zeng Q-H, Greenspan FS, Siperstein A. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol. 1988;24:305-313.
27. Levin KE, Clark AH, Duh Q-Y, Demeure M, Siperstein AE, Clark OH. Reoperative thyroid surgery. Surgery. 1992;111:604-609.
28. Ley PB, Roberts JW, Symmonds RE Jr, et al. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review. Am Surg. 1993; 59:110-114.
29. Hamming JF, Van de Velde CJ, Goslings BM, et al. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol. 1989;25:1317-1323.
30. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104:954-962.
31. Vickery ALJ, Wang C-A, Walker AM. Treatment of intrathyroid papillary carcinoma of the thyroid. Cancer. 1987;60:2587-2595.
32. Van De Velde CJH, Hamming JF, Goslings BM, et al. Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands. Eur J Cancer Clin Oncol. 1988;24:287-292.
33. Baldet L, Manderscheid JC, Glinoer D, et al. The management of differentiated thyroid cancer in Europe in 1988: results of an international survey. Acta Endocrinol. 1989;120:547-558.
34. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428.
35. Attie JN, Bock G, Moskowitz GW, Margouleff D, Dubner S. Postoperative radioactive iodine evaluation of total thyroidectomy for thyroid carcinoma: reappraisal and therapeutic implications. Head Neck. 1992;14:297-302.
36. Schlumberger M, Parmentier C, de Vathaire F, Tubiana M. Iodine-131 and external radiation in the treatment of local and metastatic thyroid cancer. In: Falk SA, ed. Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. 2nd ed. Philadelphia, Pa: Lippincott-Raven: 1997:601-617.